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Abstract
Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular disease (CVD). Advanced measures of 
cardiorespiratory fitness (CRF) are associated with CVD risk factors. The present study aimed to examine whether CVD 
risk factors can predict clinic-based measures of CRF, using the Siconolfi step test and to determine if exercise can improve 
RA patients’ cardiovascular health. Sixty-five RA patients (46 females, age 58 ± 11 years) completed assessments of CRF, 
CVD risk factors, body composition and RA characteristics. Ten patients participated in a follow-up 8-week exercise 
intervention. CRF was low (22 ml kg−1 min−1) and associated with higher diastolic blood pressure (r = − 0.37, p = 0.002), 
higher global CVD risk (r = − 0.267,  p = 0.031) and worse body composition profile (body fat, r = − 0.48, p < 0.001; waist, 
r = − 0.65, p < 0.001; hip, r = − 0.58, p < 0.001). Regular exercise significantly improved CRF (p = 0.021), lower body strength 
(p < 0.001), agility (p < 0.001), systolic blood pressure (p = 0.021), body fat (p = 0.018), waist circumference (p = 0.035), hip 
circumference (p = 0.016), disease activity (p = 0.002), disability (p = 0.007) and QoL (p = 0.004). Elevated diastolic blood 
pressure and worse body composition profile are strong predictors of clinic-based measures of CRF. CRF is an important 
determinant of CVD risk and warrants inclusion in the routine assessment of RA patients. Regular exercise can improve CRF 
and CVD risk factors without any exacerbation of disease activity and should be offered as part of routine care.
Keywords Cardiorespiratory fitness · Rheumatoid arthritis · Cardiovascular risk factors · Cardiovascular disease · Exercise
Introduction
Rheumatoid arthritis (RA) is a chronic systemic inflamma-
tory disease that is associated with 50–60% increased mor-
tality risk from cardiovascular disease (CVD) compared to 
the general population [1]. Excess CVD risk is believed to 
be dependent on both traditional and novel CVD risk factors 
such as inflammation [2]. Furthermore, other precipitating 
factors, such as persistent physical inactivity [3–5] and poor 
cardiorespiratory fitness (CRF) [6, 7] likely contribute.
Typically RA patients have a reduced CRF with reduc-
tions of 20–30% being reported by Stenstrom and Minor 
[8]. Average maximal oxygen consumption  (VO2max) val-
ues obtained from a group of female RA patients equalled 
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22 ml kg−1 min−1 [9]. The same poor CRF was observed in 
a cohort studied by our group [10]. Compared to healthy 
adults of similar age, RA patients have a significantly 
reduced CRF [8, 11–13]. Unfortunately, in rheumatology 
clinical practice, the measurement of CRF is generally non-
existent. One reason for this is that a simple method to assess 
fitness in a clinical setting did not previously exist. However, 
our group has validated the Siconolfi step test in RA patients 
[10]. This simple test is a useful tool that can be used by 
health professionals in routine clinical practice to determine 
the CRF of their RA patients.
Studies examining the associations between physical 
activity and traditional CVD risk factors in RA patients 
reveal that lower physical activity levels are associated with 
increased systolic blood pressure (SBP), total cholesterol, 
and low-density lipoprotein [4]. More recently, it has been 
shown that CRF, as measured by a maximal treadmill test, 
is also associated with several CVD risk factors [14]. Fur-
ther, 6 months of individualised exercise can improve CRF, 
individual CVD risk factors, and reduce overall CVD risk 
[15]. These studies used advanced measures of CRF which 
require expensive equipment and technical expertise thus 
limiting their use in clinical practice. To our knowledge, it 
is currently unclear if CRF, as assessed by the more simple, 
clinically applied Siconolfi step test can predict the develop-
ment of CVD in RA.
Thus, the primary aim of the present study was to 
examine the association between CRF, as measured by the 
Siconolfi step test and classical CVD risk factors and RA 
disease-related factors. A secondary aim was to investigate 
whether improving CRF via an 8-week group exercise pro-
gramme offered as part of routine care could also improve 
RA patients’ cardiovascular health and general wellbeing.
Methods
Participant recruitment
Upon obtaining ethical approval from the North Wales 
Research Ethics Committee (REC reference: 10/WNo01/11; 
approved: 22.02.2010), 65 consecutive adults attending 
rheumatology out-patient services at Betsi Cadwaladr Uni-
versity Health Board (West) were recruited. Patients diag-
nosed with RA according to the American Rheumatism 
Association’s 1987 Criteria for the Classification of Rheu-
matoid Arthritis [16] and who were deemed clinically stable 
were considered for participation. Exclusion criteria were: 
pregnancy or breastfeeding, taking beta-blockers, suffering 
from dementia, neurological impairment, cancer, an unstable 
chronic or terminal illness or any musculoskeletal impair-
ment that prevented patients completing the step test. With 
ethical approval (REC reference: 11/WA/0206; approved 
04.08.2011), ten RA patients were recruited for an additional 
longitudinal exercise study. Informed consent was obtained 
from all participants.
Protocol for cross‑sectional study
Participants were assessed in parallel to their rheumatology 
appointment. On the assessment day, the following measures 
were assessed in this approximate order:
RA factors
To assess inflammation [erythrocyte sedimentation 
rate (ESR) and C-reactive protein (CRP)] patients were 
required to have a recent blood test (< 4 weeks). The Stan-
ford Health Assessment Questionnaire (HAQ) [17] and 
the Disease Activity Score 28 (DAS 28) [18] were used to 
determine functional status (disability) and disease activity, 
respectively.
Classical CVD risk factors
Blood pressure was measured following 5 min of rest by the 
standard auscultatory technique and the values reported are 
the mean of two measurements. Fasting lipids and glucose 
were assessed within 4 weeks of the assessment session. 
Information regarding patients smoking status, family his-
tory of heart disease and current medication was obtained 
using a cardiovascular questionnaire. Global CVD risk was 
measured using the QRISK2 score [19]. The QRISK2 algo-
rithm includes CVD risk factors such as age, gender, total 
cholesterol/high-density lipoprotein ratio, blood pressure, 
diabetes and smoking status but also accounts for the pres-
ence of RA.
Body composition
Height and body mass were measured using standard 
procedures and used to calculate body mass index (BMI) 
(kg m−2). Body fat was measured using bioelectrical imped-
ance analysis (Tanita corp., Tokyo, Japan) and waist and hip 
circumference were measured to determine waist–hip ratio 
(waist:hip).
CRF
CRF was measured using the validated Siconolfi step test 
[10]. A detailed description of the protocol is provided in the 
literature [10, 20]. However, in summary, the test involves 
stepping up and down a 10-inch step in time with a metro-
nome for 3 min per stage for one to three stages.  VO2max was 
estimated from the exercise heart rate at the end of the test 
according to established equations [20].
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Protocol for longitudinal study
RA factors, CVD risk factors, and CRF were measured in the 
same manner as per the cross-sectional study at baseline and 
at 8 weeks follow-up. Other assessments included:
Physical function
The 30 s sit-to-stand test requires the participant to stand up 
and sit down as many times as they can in 30 s and measures 
lower body strength. The 8-foot “Up and Go” test requires 
the participant to rise from seated, walk eight feet around a 
cone and return to a seated position and measures agility, 
speed and balance whilst moving [21].
Quality of life (QoL) and fatigue
QoL was assessed using the SF-36 health survey [22], a 
36-item questionnaire that measures health status on eight 
different concepts. Health status is categorised into a physi-
cal component, a mental component and an overall QoL 
score. Fatigue was measured using the Multidimensional 
Assessment of Fatigue (MAF) questionnaire [23], a 16-item 
scale that measures fatigue according to four dimensions 
(degree, distress caused, timing, impact on daily living).
Intervention: 8‑week exercise programme
In line with ACSM guidelines [24] participants exercised 
three times per week for 8 weeks at the physiotherapy gym, 
Gwynedd Hospital. Exercise sessions were supervised by 
an exercise physiologist. Each session lasted 60 min and 
consisted of 3 × 10 min aerobic exercises. Participants chose 
the exercise and order in which they were completed (tread-
mill, bike, rower, stepper, cross-trainer). Exercise intensity 
increased from 55 to 85% predicted heart rate max (220-age) 
during the programme and included both continuous and 
interval training patterns. Heart rate and ratings of perceived 
exertion (RPE) were monitored throughout. After aerobic 
exercise, participants completed resistance training exercises 
(calf raises, leg raises, knee raises, squats and abdominal 
curls). Participants completed 15 repetitions × 2 sets of 
each exercise at week 1 and progressed to 15 repetitions, 10 
pulses × 3 sets by week 8.
Statistical analysis
Cross‑sectional study
Data analysis was performed using the Statistical Package 
for Social Sciences version 19.0 (SPSS Inc. Chicago, Illi-
nois, USA). The Kolmogorov–Smirnov test of normality was 
used to assess the distribution of variables. Variables not 
normally distributed were log transformed. Non-parametric 
tests were performed on data that remained not normally 
distributed (diastolic blood pressure, glucose, ESR, CRP, 
tender joints, swollen joints, disease duration, HAQ).
Pearson’s correlation coefficient (parametric), Spearman’s 
correlation coefficient (non-parametric), logistic regression 
analysis and analysis of covariance (ANCOVA) were per-
formed to assess the association between CRF and CVD 
risk factors, global CVD risk scores, body composition and 
RA disease factors. Hierarchical multiple regression was 
performed to determine the factors (independent variables) 
which best predict CRF (dependent variable). Statistical sig-
nificance was set at p < 0.05 for all analyses unless otherwise 
stated.
Longitudinal study
Dependent t test analysis was used to determine significant 
differences between pre- and post-test measures. The effect 
size was calculated using eta squared (t2 ÷ t2 + (N−1)). Sig-




65 RA patients (71% female) successfully completed 
the Siconolfi step test (mean ± SD; age 58 ± 11  years; 
disease duration 10 ± 8  years). Predicted CRF was 
22.0 ± 5.9  ml  kg−1  min−1 for the entire cohort and 
20.3 ± 4.8 ml kg−1 min−1 and 26.3 ± 6.2 ml kg−1 min−1 for 
females and males, respectively.
RA patients were categorised as overweight (BMI > 25). 
65% of RA patients were overweight or obese according 
to their body fat percent and the prevalence of being over-
weight or obese was higher in female RA patients (70%) 
compared to males (53%).
RA patients had well-controlled disease with low levels 
of inflammation (ESR = 12.0 mm h−1; CRP = 4.0 mg l−1), 
disease activity (DAS 28 CRP = 2.2) and disability 
(HAQ = 0.5). See Table 1. Patients were treated with dis-
ease-modifying anti-rheumatic drugs (DMARDs) includ-
ing methotrexate (66%), leflunomide (18%), sulphasalazine 
(14%) and hydroxychloroquine (9%) and biologic therapy 
(23%). 57% of patients were receiving monotherapy, 37% 
of patients were receiving combination therapy and 6% of 
patients were not being treated with DMARDs.
Global CVD risk was moderate to high (16.3%). 35% 
of patients were classified as having metabolic syndrome 
based on the clustering of risk factors (abdominal obesity, 
1762 Rheumatology International (2019) 39:1759–1766
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hyperglycaemia, low high-density lipoprotein choles-
terol (HDL-c), high triglycerides (TG) and hypertension). 
According to the NCEP Adult treatment Panel (ATP III), a 
diagnosis of metabolic syndrome requires at least three of 
the five criteria [25].
Correlation/regression analysis
CRF inversely correlated with diastolic blood pressure 
(DBP) and global CVD risk score but not with any other 
CVD risk factors, see Table 2.
No significant associations were observed between 
CRF and family history of heart disease (OR = 1.06, 95% 
CI = 0.96–1.17; p = 0.275), diabetes (OR = 1.07, 95% 
CI = 0.93–1.24; p = 0.321), hypertension (OR = 1.08, 95% 
CI = 0.98–1.18; p = 0.112), dyslipidemia (OR = 1.08, 95% 
CI = 0.98–1.19; p = 0.105), smoking status (OR = 0.94, 
Table 1  Body composition, RA characteristics and CVD risk factors 
of RA patients
Values are mean (SD), median [IR] or percentage of patients (%), 
N = 65
BMI body mass index, ESR erythrocyte sedimentation rate, CRP 
C-reactive protein, CCP cyclic citrullinated peptide, DAS disease 
activity score, HAQ health assessment questionnaire, +CRP value of 4 
was used for CRP values < 5, SBP systolic blood pressure, DBP dias-
tolic blood pressure, TC total cholesterol, TG triglycerides, LDL-c 
low-density lipoprotein, HDL-c high-density lipoprotein, MetS meta-
bolic syndrome, NCEP national cholesterol education programme
a Hypertensive; SBP > 140  mmHg, DBP > 90  mmHg or on medication, 
Dyslipidemia; TC > 5.2 mmol/l, LDL-c > 3.4 mmol/l, TG > 1.8 mmol/l or 
on medication




Weight (kg) 71.5 (13.6)
BMI (kg m−2) 26.3 (4.2)
Body Fat (%) 35.3 (12.1)
Body fat overfat/obese (%) 65
Waist (cm) 87.4 (11.1)
Hip (cm) 98.1 (9.1)
Waist:hip 0.88 (0.6)
RA characteristics
Rheumatoid factor positive (%) 68
CCP positive (%) 86
ESR (mm h−1) 12.0 [13.0]
CRP (mg l−1) 4.0 [5.0]+
DAS 28 CRP 2.2 [1.3]
HAQ (0–3) 0.50 [1.10]
CVD risk factors
Hypertensive (%)a 60
SBP (mmHg) 138 (19)
DBP (mmHg) 80 [17]
Anti-hypertensive medication (%) 26
Dyslipidemia (%)a 71
TC (mmol l−1) 5.4 (1.2)
TG (mmol l−1) 1.2 [0.8]
LDL-c (mmol l−1) 3.2 [1.0]
HDL-c (mmol l−1) 1.6 (0.5)
TC/HDL ratio 3.7 (2.1)
Anti-hyperlipidemia medication (%) 25
Diabetics (%) 8
Glucose (mmol l−1) 5.0 [0.5]
Current smoker (%) 17
Ex smoker (%) 48
Family history CVD (%) 26
QRISK2 (%) 16.3 [19.1]
Metabolic syndrome (NCEP) (%) 35
Table 2  Associations between CRF and CVD risk factors, body com-
position and RA characteristics
Values are Pearson’s or Spearman’s correlations controlling for age 
and gender, N = 65
SBP systolic blood pressure, DBP diastolic blood pressure, TC total 
cholesterol, TG triglycerides, LDL-c low-density lipoprotein, HDL-
c high-density lipoprotein, BMI body mass index, ESR erythrocyte 
sedimentation rate, CRP C-reactive protein, CCP cyclic citrullinated 
peptide, DAS disease activity score, VAS visual analogue scale, HAQ 
health assessment questionnaire
*Significant correlation, p < 0.05
Correlation p
CVD risk factors
SBP (mmHg) − 0.057 0.659
DBP (mmHg) − 0.369 0.002*
TC (mmol l−1) − 0.137 0.301
TG (mmol l−1) − 0.122 0.374
LDL-c (mmol l−1) − 0.045 0.749
HDL-c (mmol l−1) 0.073 0.595
Glucose (mmol l−1) − 0.228 0.115
QRISK2 (%) − 0.267 0.031*
Body composition
Weight (kg) − 0.641 < 0.001*
BMI (kg m−2) − 0.614 < 0.001*
Body fat percent (%) − 0.481 < 0.001*
Waist (cm) − 0.651 < 0.001*
Hip (cm) − 0.584 < 0.001*
Waist: hip − 0.254 0.045*
RA characteristics
Disease duration (years) 0.003 0.983
ESR (mm h−1) − 0.104 0.410
CRP (mg l−1) − 0.036 0.774
DAS 28 CRP 0.025 0.845
HAQ (0–3) − 0.255 0.040*
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95% CI = 0.86–1.04; p = 0.212), or metabolic syndrome 
(OR = 1.07, 95% CI = 0.97–1.18; p = 0.172).
CRF inversely correlated with all body composition 
measures (weight, BMI, body fat percent, waist circum-
ference, hip circumference and waist:hip) when adjusting 
for age and gender (see Table 2). Waist circumference was 
most strongly associated with CRF.
CRF was 24% lower in obese patients com-
pared to non-obese (19.1 ± 4.9  ml  kg−1  min−1 versus 
23.7 ± 5.8 ml kg−1 min−1, p = 0.002). Obesity remained 
a significant and independent predictor of CRF using 
ANCOVA, with age, gender and disease duration as 
covariates, (F1, 60 = 8.3; p < 0.01).
For RA disease variables, CRF correlated significantly 
with HAQ scores with better CRF associated with less 
reported disability. CRF did not correlate with any other 
RA disease factors (see Table 2).
Hierarchical multiple regression assessed the ability of 
three measures (DBP, body fat percent and HAQ) to pre-
dict level of CRF. DBP was entered at step 1, explaining 
10.3% of variance in CRF  (R2 change 0.103). After entry 
of body fat percent at step 2, the total variance explained 
by the model was 39% (F (2,62) = 19.81, p < 0.001). Body 
fat percent explained an additional 28.7% of the variance 
in CRF, after controlling for DBP (R2 change 0.287). 
After entry of HAQ at step 3, the total variance explained 
by the model was 40.2% (F (3,61) = 13.65, p < 0.001). 
In the final model, only DBP (beta − 0.29, p < 0.01) and 
body fat percent (beta − 0.53, p < 0.001) were significant 
predictors of CRF.
Longitudinal study
Of the 65 patients assessed in the cross-sectional study, 
10 patients (8 females; age 64 ± 6 years; disease dura-
tion 11 ± 12 years) agreed to participate and completed 8 
weeks of exercise. Compliance to training was excellent 
and participants completed on average 22 sessions (range 
17–24). Results are displayed in Table 3.
CRF improved significantly after the exercise pro-
gramme (p = 0.021). Relative to baseline, fitness 
improved by 13%, lower body strength improved by 54% 
and agility improved by 17%. SBP decreased by 7 mmHg 
(p = 0.021). There were no changes in fasting lipids or 
glucose, LDL-c increased by 0.2 mmol l−1 but remained 
within normal range. Body fat decreased by 9%, waist 
circumference by 2% and hip circumference decreased by 
3% with an overall reduction in total weight (1.4 kg) and 
BMI (0.6 kg m−2). There was no change in inflammation, 
however, disease activity, pain, HAQ, fatigue and QoL 
improved significantly.
Discussion
The present study revealed that in patients with RA, DBP 
and body composition (specifically body fat, waist and 
hip circumference) were the strongest predictors of CRF 
as measured by the validated Siconolfi step test. Further, 
an 8-week exercise intervention revealed improvement in 
CRF and physical function, several classical CVD risk 
factors and RA factors. Collectively, these findings sug-
gest that CRF is an important determinant of CVD risk 
and warrants inclusion in the routine assessment of RA 
patients. The present study also suggests that regular exer-
cise can improve CVD risk, RA disease and general well-
being and thus should be prescribed as part of routine care.
The assessment of CRF using the previously validated 
Siconolfi step test supports our previous findings about the 
low CRF of RA patients (22 ml kg−1 min−1). Importantly, 
poor CRF was associated with higher DBP, higher global 
CVD risk and worse body composition profile. Patients with 
low CRF tended to be heavier, fatter and had a larger waist 
and hip circumference. The strong association between CRF 
and body composition is partially explained by the inclusion 
of body weight in the CRF calculation. However, despite 
this, these results remain consistent with previous findings 
[14, 26, 27]. The present study shows that CRF is signifi-
cantly lower (24%) in patients that are classified as obese, 
even after controlling for age, gender and disease duration.
Previous research suggests that physically active RA 
patients have lower SBP, better lipid profiles and favour-
able body composition when compared to physically 
inactive patients [4] and that these positive effects are 
mediated by higher CRF [14]. Interestingly, regardless of 
fitness level, it has also been shown that individuals with 
higher visceral adipose tissue also have higher blood pres-
sure [28]. The results of the present study suggest that 
the association between poor CRF and high DBP may 
be due to individuals who are less fit also having higher 
levels of body fat. The exact biological mechanism for 
this observation is unclear, however, it is possible that the 
increased production of proinflammatory cytokines from 
visceral adipose tissue [29] directly injures the vascular 
endothelium, subsequently increasing blood pressure 
[30]. In addition, the abnormal production of proinflam-
matory cytokines derived from metabolically active fat 
may also be exacerbated by the inflammatory nature of 
RA disease itself [31]. Interestingly, a sub-analysis of the 
present study provides support for this hypothesis, patients 
who were classified as having a high waist circumference 
(≥ 88 cm for females, ≥ 102 cm for males) did have sig-
nificantly higher DBP (p = 0.042). Systolic blood pressure 
was on average higher for individuals with a high waist 
circumference, but this was not statistically significant.
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There is a large body of evidence that suggests regular 
exercise is beneficial to RA patients [32]. Regular aero-
bic and muscle strengthening exercise have been shown to 
improve CRF [15, 33, 34], muscle strength [35, 36], body 
composition [15, 37, 38] and CVD risk factors [15]. Impor-
tantly, these benefits are all achieved without any exacerba-
tion of disease activity. The results of the present study show 
that 8 weeks of supervised exercise offered as part of routine 
care, not only significantly improves CRF and physical func-
tion, but also significantly improves several CVD risk factors 
which include SBP and body composition. These beneficial 
effects were all achieved without any exacerbation of disease 
activity. In fact, 8 weeks of supervised exercise resulted in 
a significant improvement in disease activity, pain, fatigue 
and quality of life.
The exercise programme implemented was based on 
current exercise guidelines [24] and the findings confirm 
the programme was of sufficient intensity, duration, fre-
quency and progression to elicit positive changes. CRF 
improved by 13%, indicating a large effect and is con-
sistent with findings from previous research [15, 33, 34]. 
Lower body strength improved by 54%, this is greater than 
the 30% improvement reported by Lemmey et al. [35] and 
the 30.5% reported by Law et al. [39] but is in line with the 
59% improvement observed by Matsuda et al. [36], who 
investigated the beneficial effects of a 6-week home exer-
cise programme. Similarly, Matsuda et al. [36] reported a 
25% improvement in agility, whilst patients in the current 
investigation improved by 17%.
Table 3  Effect of 8 weeks of 
supervised group exercise on 
fitness and function, CVD risk 
factors, body composition and 
RA characteristics
Values are mean ± SD, N = 10
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, TG 
triglycerides, LDL-c low-density lipoprotein, HDL-c high-density lipoprotein, ESR erythrocyte sedimenta-
tion rate, CRP C-reactive protein, DAS disease activity score, HAQ health assessment questionnaire
*Significant difference between pre- and post-scores, p < 0.05. Effect size was calculated using eta squared, 
where 0.01 = small effect, 0.09 = moderate effect, 0.25 = large effect
Pre Post p Effect Size
Fitness and function
Predicted  VO2max 
(ml kg−1 min−1)
21.7 ± 8.4 24.6 ± 8.4 0.021* 0.48
30 s sit-to-stand (n) 11.1 ± 2.6 17.1 ± 1.7 < 0.001* 0.90
8-ft Up and Go (s) 5.9 ± 0.4 4.9 ± 0.3 < 0.001* 0.91
CVD risk factors
SBP (mmHg) 133.2 ± 14.7 125.8 ± 11.9 0.021* 0.46
DBP (mmHg) 76.2 ± 5.9 74.6 ± 7.5 0.448 0.06
TC (mmol l−1) 5.3 ± 0.9 5.4 ± 0.8 0.534 0.04
TG (mmol l−1) 1.3 ± 0.8 1.2 ± 0.7 0.785 0.01
LDL-c (mmol l−1) 2.9 ± 0.7 3.1 ± 0.6 0.034* 0.41
HDL-c (mmol l−1) 1.8 ± 0.4 1.7 ± 0.4 0.112 0.26
Glucose (mmol l−1) 4.9 ± 0.5 4.9 ± 0.6 0.434 0.07
QRISK2 (%) 17.01 ± 8.30 16.87 ± 8.41 0.670 0.02
Body composition
Weight (kg) 66.8 ± 15.6 65.4 ± 14.2 0.069 0.32
BMI (kg m−2) 25.7 ± 4.4 25.1 ± 3.8 0.056 0.35
Body fat (%) 34.0 ± 12.6 31.0 ± 11.9 0.018* 0.48
Waist (cm) 82.6 ± 11.1 80.8 ± 10.3 0.035* 0.41
Hip (cm) 98.7 ± 9.4 95.4 ± 6.9 0.016* 0.49
Waist: hip 0.84 ± .06 0.84 ± .07 0.226 0.16
RA characteristics
ESR (mm h−1) 3.2 ± 1.9 2.3 ± 0.7 0.081 0.30
CRP (mg l−1) 4.0 ± 0.0 4.8 ± 2.5 0.343 0.10
DAS 28 CRP 2.9 ± 0.6 2.2 ± 0.5 0.016* 0.49
Pain (0–100) 24.1 ± 17.9 12.4 ± 9.5 0.032* 0.42
Fatigue (1–50) 18.8 ± 12.6 11.9 ± 9.2 0.019* 0.48
HAQ (0–3) 0.81 ± .65 0.33 ± .29 0.007* 0.57
SF36 total score 90.7 ± 11.9 105.5 ± 8.0 0.004* 0.62
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Importantly, 8 weeks of regular exercise resulted in a 
significant reduction in SBP. Average SBP at baseline was 
133 mmHg, which is classified as pre-hypertension, 8 weeks 
of exercise reduced SBP by 7 mmHg, representing a clini-
cal and large effect [40]. DBP was within normal range at 
baseline and thus is not surprising that no significant change 
was observed. Similarly, RA patients had an acceptable 
lipid profile at baseline and no changes were observed post 
intervention.
Obesity is a significant contributor to CVD [41], so 
results of the present cross-sectional study highlights that the 
level of obesity in the RA population is a cause for concern. 
However, findings from the longitudinal investigation pro-
vide support for an effective strategy for managing this issue. 
8 weeks of regular exercise, offered as part of routine care, 
can significantly improve RA patients’ body composition. 
The present study suggests that excess adiposity is linked 
with higher DBP and poor CRF. It could therefore be argued 
that reducing adiposity is an essential target for treatment. It 
must be acknowledged that improvements in body composi-
tion were achieved without any change in diet. These find-
ings are similar to those reported by previous investigations 
[15, 37, 38].
Limitations of the present study include the cross-sec-
tional design of the study, meaning no conclusions can be 
made on the cause and effect of CRF, CVD risk and future 
cardiovascular health of RA patients. Additionally, patients 
unable to complete the step test were excluded which sug-
gests the cohort investigated are likely the fittest patients. 
Despite this, the present study has revealed low CRF and a 
high prevalence of obesity. A major strength of the current 
investigation is the addition of the longitudinal investigation. 
To our knowledge, this is the second study to investigate the 
beneficial effects of exercise on CVD risk in RA. Our inves-
tigation highlights that RA patients can participate in regular 
exercise and benefit from improvements in cardiovascular 
health and general wellbeing. However, the longitudinal 
study is not without limitations. Compared to the cross-sec-
tional study, RA patients’ CVD risk factors, inflammation 
and disease activity were not markedly elevated at baseline. 
Thus, the beneficial effects of exercise in patients with more 
active disease and a worse CVD risk profile remains to be 
determined. Second, the sample size was small, with no 
control group, randomisation or blinding. Lastly, the short 
duration of the longitudinal study means that no conclusions 
can be made on CRF as measured by the Siconolfi step test 
and hard outcomes like the future development of CVD in 
RA. Future research is needed to determine if results from 
the Siconolfi step test can be used to predict future CVD. 
Despite these limitations, this study has identified important 
CVD risk factor targets for treatment and has designed an 
effective exercise programme that could be offered as part 
of routine care.
Conclusion
RA patients have poor CRF as assessed by the Siconolfi 
step test and this is associated with higher DBP, higher 
global CVD risk and obesity. This investigation highlights 
the importance of including CRF, as measured by the 
step test, as an indicator of CVD risk. The present study 
also shows that regular exercise offered as part of routine 
care can help improve RA patients overall cardiovascular 
health, wellbeing and QoL. Future research is required 
to establish how these improvements can be sustained in 
patients with a wide range of disease activity and finally, 
to determine whether or not such a treatment, offered as 
part of routine care, is financially viable for the national 
health service.
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